Concord Medical Co., Ltd.

TPEX:6518 Stock Report

Market Cap: NT$896.7m

Concord Medical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Concord Medical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth19.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Here's Why Concord Medical (GTSM:6518) Can Manage Its Debt Responsibly

Apr 30
Here's Why Concord Medical (GTSM:6518) Can Manage Its Debt Responsibly

Are Dividend Investors Making A Mistake With Concord Medical Co., Ltd. (GTSM:6518)?

Mar 31
Are Dividend Investors Making A Mistake With Concord Medical Co., Ltd. (GTSM:6518)?

The Trends At Concord Medical (GTSM:6518) That You Should Know About

Mar 03
The Trends At Concord Medical (GTSM:6518) That You Should Know About

Here's How We Evaluate Concord Medical Co., Ltd.'s (GTSM:6518) Dividend

Dec 29
Here's How We Evaluate Concord Medical Co., Ltd.'s (GTSM:6518) Dividend

Returns On Capital At Concord Medical (GTSM:6518) Paint An Interesting Picture

Nov 30
Returns On Capital At Concord Medical (GTSM:6518) Paint An Interesting Picture

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Concord Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:6518 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20248634759109N/A
3/31/20248484541111N/A
12/31/20238334324113N/A
9/30/20238414327113N/A
6/30/20238504331113N/A
3/31/20238694774134N/A
12/31/202288951116155N/A
9/30/202285750133163N/A
6/30/202282449149172N/A
3/31/202278242144155N/A
12/31/202173934140137N/A
9/30/20217662998115N/A
6/30/2021794245692N/A
3/31/2021802222388N/A
12/31/202081020-1084N/A
9/30/202079023093N/A
6/30/2020770269101N/A
3/31/20207672935116N/A
12/31/20197643161131N/A
9/30/20197472759118N/A
6/30/20197312257104N/A
3/31/20197171953102N/A
12/31/2018703154999N/A
9/30/2018691122381N/A
6/30/20186799-463N/A
3/31/20186635N/A63N/A
12/31/20176471N/A64N/A
9/30/20176392N/A72N/A
6/30/20176313N/A81N/A
3/31/20176197N/A66N/A
12/31/201660711N/A51N/A
9/30/201658619N/A39N/A
6/30/201656528N/A27N/A
3/31/201654234N/A26N/A
12/31/201552040N/A24N/A
9/30/201547237N/A62N/A
6/30/201542434N/A100N/A
3/31/201538630N/A99N/A
12/31/201434926N/A97N/A
9/30/201430121N/A84N/A
6/30/201425315N/A65N/A
3/31/20141909N/A32N/A
12/31/20131283N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 6518's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 6518's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 6518's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 6518's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 6518's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 6518's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y